Back

Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers

European Journal of Preventive Cardiology

15 April 2020
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
COVID-19-induced heart failure: pathophysiologic mechanisms, and their relevance to clinical practice.
21 May 2022
thumbnail
Congress Presentation
Angiotensin-converting enzyme inhibitors for aortic stenosis: a drug-target mendelian randomisation study
1 September 2025
thumbnail
Congress Presentation
Efficacy and safety of sacubitril/valsartan in patients with acute decompensated heart failure: a systematic review and meta-analysis
2 December 2022
thumbnail
Congress Presentation
Cardioprotective effect of angiotensin converting enzyme 2 activation in hESC-derived cardiomyocytes under diabetic condition
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources